from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3482c/-

LFCtreatmentdescriptionclass of inhibitor

-1.045

Amikacinug/mL Amikacintranslation

-1.412

Cap5-10ug/mL Capreomycintranslation

-1.917

Rox10-50 ug/mL Roxithromycintranslation

-0.720

SM2-5 ug/mL Streptomycintranslation

-1.383

Tet5-10 ug/mL Tetracyclinetranslation

0.071

Rif0.2-5ug/mL Rifampicintranscription

0.012

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.345

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.965

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.164

CPZ10-50 ug/mL Chlorpromazinerespiration

0.080

Clofazimine10-13 ug/mL Clofaziminerespiration

-1.074

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.314

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.762

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

1.212

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-1.214

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.035

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.509

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.408

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.545

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.970

KCN5-20 ug/mL Potassium cyaniderespiration

0.237

NaN30.2-2 mM Sodium aziderespiration

-0.192

Nigericin50 uM Nigericinrespiration

0.180

TRC10-150 ug/mL Triclosanrespiration

0.158

TRZ10-25 ug/mL Thioridazinerespiration

-1.461

Valinomycin0.5-10 uM Valinomycinrespiration

-1.938

ZnSO42 mM ZnSO4respiration

0.118

menadione6-10 ug/mL Menadionerespiration

-0.073

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.312

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.648

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.356

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.708

NRP_1Non-replicating persistence stage 1dosRassociated

-0.250

Amp0.2mg/mL AmpicillincellWall

-0.535

Cephalexin20-100 ug/mL CephalexincellWall

-0.602

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.235

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.184

EMB10-20 ug/mL EthambutolcellWall

-1.139

Eta12-40 ug/mL EthionamidecellWall

-1.118

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.351

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.591

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-1.222

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

1.136

BZA0.12 mg/mL BenzamidearomaticAmides

1.016

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.525

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.027

H2O24 mM hydrogen peroxideDNAdamaging

-0.246

Levo10 ug/mL LevofloxacinDNAdamaging

0.641

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.615

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.046

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.238

UVUV-irradiationDNAdamaging

0.648

ARP41-4 ug/mL Antitubercular compound ARP4?

0.131

Antimycin12.5-50 ug/mL Antimycin A?

-0.735

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.267

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.128

PA_2110-50 ug/mL Antitubercular compound PA-21?

-1.786

PA8240.2-2 ug/mL PA-824?

-0.314

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.131

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.221

Verapamil50 uM Verapamil?

0.121

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.809

methoxatin10-20 ug/mL Methoxatin?